CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Director sold 22,000 shares at $10.05 ($221,025)
- 4 Other disposition President and CEO disposed of 233,532 shares (other)
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 4 Planned sale President and CEO sold 72,559 shares at $9.16 ($664,350)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 22,000 shares at $9.07 ($199,617)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale SVP, Chief Accounting Officer sold 7,711 shares at $9.12 ($70,324)
- 4 Other disposition EVP & Chief Financial Officer disposed of 2,500 shares (other)
- 144 Insider Sale of Securities
Page 3 of 41 · 804 filings